Throughout his career, Dr. Tyrone Malloy has combined clinical practice with research and the advancement of reproductive healthcare.

In 1995, while serving as Medical Director of the Feminist Women’s Health Center in Atlanta, Dr. Malloy represented the southeastern United States as a Principal Investigator in five clinical trials involving mifepristone and misoprostol. Data generated through these trials contributed to the FDA approval process for mifepristone for medication abortion.

From Clinical Practice to Clinical Research

Dr. Malloy’s involvement in this research built upon his experience in Obstetrics and Gynecology and reproductive healthcare. He was first introduced to the management of second- and third-trimester abortion care while attending the Johns Hopkins University School of Medicine, where he earned his medical degree in 1975.

As a Principal Investigator, Dr. Malloy participated directly in the clinical research process, contributing data as part of the southeastern U.S. research effort.

Contributing to Reproductive Healthcare Research

Dr. Malloy’s involvement in these trials represents one part of a career that has included direct patient care, clinical research, medical education, and physician leadership.

His work in medication-abortion research reflects a broader theme throughout his professional career: contributing not only to patient care, but also to the medical research and clinical knowledge available to physicians and patients.